Advertisement
Advertisement
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
69.45
USDSponsored
0.00
-0.01%
Aug 12, 13:23 UTC -4
Open
Tarsus Pharmaceuticals, Inc. Common Stock Profile
About
Info & Links
CEO
Bobak Azamian
Headquarters
IRVINE, CA 92618, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
12
Employees
370
Tarsus Pharmaceuticals, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
3.05B
Enterprise Value
2.92B
Enterprise Value/EBITDA(ttm)
-58.75
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
4.90
Price to Book(mrq)
8.58
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
93.26%
Operating Margin(ttm)
-7.67%
Profit Margin(ttm)
-7.77%
Return on Equity(ttm)
-13.53%
Return on Invested Capital(ttm)
-11.18%
Return on Assets(ttm)
-8.12%
Income Statement
Revenue(ttm)
606.33M
Revenue Per Share(ttm)
13.82
Gross Profit(ttm)
565.59M
EBITDA(ttm)3
-49.63M
Net Income Available to Common(ttm)
-46.48M
Diluted EPS(ttm)
-1.09
Share Statistics
Beta (5Y Monthly)
0.53
52-Week Change
38.72%
S&P 500 52-Week Change
20.28%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
43.88M
Dividend Yield
0.00%
Float4
39.65M
% Held by Insiders
9.64%
% Held by Institutions
90.01%
Balance Sheet
Total Cash(mrq)
449.69M
Total Cash Per Share(mrq)
10.25
Total Debt(mrq)
72.76M
Total Debt/Equity(mrq)
20.99%
Current Ratio(mrq)
3.20%
Quick Ratio(mrq)
3.17%
Book Value Per Share(mrq)
8.01
Cash Flow
Operating Cash Flow Per Share(ytd)
0.84
Free Cash Flow(ytd)
26.68M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement